SEC Form 4 research
| Issuer | CG Oncology, Inc. |
|---|---|
| Tickers | CGON |
| Reporting owners | 28 |
| Officers and directors | 5 |
| Last public filing | 2026-10-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-15 | Kalofonos Isabel | A | 92,000 | $0 | Not reported |
| 2026-10-19 | 2026-10-15 | POST LEONARD E | S | 500 | $62.48 | Not reported |
| 2026-10-19 | 2026-10-15 | POST LEONARD E | S | 500 | $61.65 | Not reported |
| 2026-09-17 | 2026-09-15 | POST LEONARD E | S | 1,000 | $72.98 | Not reported |
| 2026-08-18 | 2026-08-14 | POST LEONARD E | S | 1,000 | $74.54 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.